Therapeutic Uses
Antiretroviral / Anti-HIV
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(4S)-6-Chloro-4-[2-(cyclopropyl-1,2,2,3,3-d5)ethynyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
Yes -Refer MSDS for accurate information
Efavirenz-d5 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Efavirenz-d5 usage and description
Efavirenz D5 is a medication that is commonly used to treat HIV infection. It belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs), which work by blocking the activity of the HIV reverse transcriptase enzyme. This enzyme is responsible for converting viral RNA into DNA, which can then be integrated into the host cell's genome and lead to the production of new virus particles.
Efavirenz D5 is chemically similar to the non-deuterated version of the drug, Efavirenz. However, it contains five deuterium atoms, which can be used in pharmacokinetic studies to track the drug's metabolism and distribution in the body. This can provide valuable information on the drug's safety and efficacy, as well as help to optimize dosing regimens.
The recommended dosage of Efavirenz D5 varies depending on the patient's age, weight, and other medical conditions. It is typically taken once daily, either alone or in combination with other antiretroviral medications. Common side effects of the drug include headache, dizziness, nausea, and rash. Less frequently, it can cause more serious side effects such as liver toxicity or psychiatric symptoms.
In conclusion, Efavirenz D5 is an important medication for the treatment of HIV infection, and its chemical properties make it useful for pharmacokinetic studies. However, like all medications, it should be used only under the guidance of a healthcare professional and with careful monitoring for potential side effects.
